Regular Article
Nucleoredoxin, Glutaredoxin, and Thioredoxin Differentially Regulate NF-κB, AP-1, and CREB Activation in HEK293 Cells

https://doi.org/10.1006/bbrc.2000.3106Get rights and content

Abstract

Well-established mechanisms for regulation of protein activity include thiol-mediated oxidoreduction in addition to protein–protein interactions and phosphorylation. Nucleoredoxin (NRX), glutaredoxin (GRX), and thioredoxin (TRX) have been shown to act as a potent thiol reductase and reactive oxygen species regulator. They constitute a oxidoreductase superfamily and have been suggested as a candidate operating in the redox regulation of gene expression. We demonstrated here that intracellular localization of these redox molecules differ from each other and that the redox molecules differentially regulate NF-κB, AP-1, and CREB activation induced by TNFα, PMA, and forskolin and by expression of signaling intermediate kinases, NIK, MEKK, and PKA in HEK293 cells. This is a first report that describes involvement of NRX and GRX and differences from TRX in transcriptional regulation of NF-κB, AP-1, and CREB in living cells.

References (27)

  • S.W. Kang et al.

    Characterization of a mammalian peroxiredoxin that containes one conserved cysteine

    J. Biol. Chem.

    (1998)
  • S.W. Kang et al.

    Mammalian peroxiredoxin isoforms can reduce hydrogen peroxide generated in response to growth factors and tumor necrosis factor-α

    J. Biol. Chem.

    (1998)
  • H.L. Pahl et al.

    Oxygen and the control of gene expression

    BioEssays

    (1994)
  • Cited by (175)

    • Impact of selenium nanoparticles in the regulation of inflammation

      2022, Archives of Biochemistry and Biophysics
    View all citing articles on Scopus

    Abbreviations used: NRX; nucleoredoxin, GRX; glutaredoxin; TRX, thioredoxin; NF-κB, nuclear factor κ B; AP-1, activating protein 1; CREB, CRE binding protein; NIK, NF-κB inducible factor; MEKK, MAP/Erk kinase kinase kinase; DMEM; Dulbecco's modified Eagle's medium.

    1

    To whom correspondence should be addressed at Department of Anesthesia, Kyoto University Hospital Kyoto University, 54, Shogoin Kawahara-Cho, Sakyo-Ku, Kyoto, 606-8507, Japan. Fax: +81-75-752-3259. E-mail: [email protected].

    2

    Present address: Laboratory of Biomedical Genetics, Graduate School of Pharmaceutical Sciences, the University of Tokyo, Bunkyo-Ku, Tokyo 113-0033, Japan.

    View full text